- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07244211
MAPT 프로토콜: 고관절 골절 후 조기 회복을 위한 고정술 대 관절성형술 수술 치료(FASTER-HIP) (FASTER-HIP)
근골격계 적응형 플랫폼 시험(MAPT): 고관절 골절 후 조기 회복을 위한 고정술 대 관절성형술 수술 치료(FASTER-HIP)
This study is an intervention domain of the Musculoskeletal Adaptive Platform Trial. The primary goal of this pragmatic, randomized, open-label, comparative effectiveness trial is to evaluate if arthroplasty is superior to internal fixation when used to treat minimally displaced femoral neck fractures in older adults ≥60 years old. We hypothesize that arthroplasty will reduce death, preserve ambulation, increase days alive and out of hospital, and improve health status compared to internal fixation within 4 months and 12 months from randomization.
연구 개요
상세 설명
The Musculoskeletal Adaptive Platform Trial (MAPT) is an adaptive platform trial protocol that enables the simultaneous evaluation of multiple interventions (i.e., intervention domains) within a consistent infrastructure. Each intervention being evaluated in the MAPT will have an intervention domain protocol that describes additional eligibility criteria, interventions, secondary outcomes, and statistical stopping rules. The overarching objective of the MAPT trial platform is to incrementally decrease decisional uncertainty and identify treatments that will optimize patient outcomes. The platform focuses on the comparative effectiveness of available treatment options.
Adult patients aged 60 years or older with a low-energy minimally displaced femoral neck fracture treated with surgery are eligible for the FASTER-HIP intervention domain. Nearly half of all elderly hip fractures are femoral neck fractures, and approximately 20% are minimally displaced. Internal fixation has remained the treatment of choice for these injuries because these fractures can be fixed in situ, and the surgical implants can be inserted with little surgical dissection. Patients treated with internal fixation experience high complication rates, with the pooled risk of reoperation and mortality each above 14%. Preliminary data have suggested arthroplasty for minimally displaced fractures may lead to better patient outcomes, including improved ambulation, fewer reoperations, and a lower risk of death compared to internal fixation. While the preliminary data supporting the use of arthroplasty for minimally displaced fractures is promising, the necessary evidence to make this practice change remains lacking.
FASTER-HIP is a pragmatic, randomized, open-label, comparative effectiveness trial comparing hip arthroplasty versus internal fixation for minimally displaced femoral neck fractures. Randomization in this domain occurs in a 1:1 ratio (hip arthroplasty:internal fixation). The primary outcome is a composite of death within 120 days, ambulation status at 120 days, and days alive and out of hospital within 120 days of randomization. The primary outcome will be hierarchically assessed using the Win ratio. Secondary outcomes include the same composite at 365 days, individual components of the composite, health-related quality of life (EQ-5D-5L), and pain scores during hospitalization.
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Joseph Patterson, MD
- 전화번호: +13234426984
- 이메일: OrthoTraumaResearch@med.usc.edu
연구 장소
-
-
-
Grålum, 노르웨이, 1714
- 모병
- Sykehuset Østfold HF / Østfold Hospital Trust
-
연락하다:
- Frede Frihagen, MD
-
연락하다:
-
수석 연구원:
- Frede Frihagen, MD
-
-
-
-
California
-
Irvine, California, 미국, 92660
- 모병
- University of California, Irvine
-
수석 연구원:
- Gerard Slobogean, MD
-
연락하다:
- Gerard Slobogean, MD
- 전화번호: 714-456-1699
- 이메일: gsloboge@hs.uci.edu
-
Los Angeles, California, 미국, 90048
- 모병
- Cedars-Sinai Medical Center
-
수석 연구원:
- Carol Lin, MD
-
연락하다:
- Carol Lin, MD
- 이메일: carol.lin@cshs.org
-
Los Angeles, California, 미국, 90033
- 모병
- University of Southern California
-
수석 연구원:
- Joshua L Gary, MD
-
연락하다:
- Joshua Gary, MD
- 전화번호: +13234426984
- 이메일: OrthoTraumaResearch@med.usc.edu
-
Los Angeles, California, 미국, 90033
- 모병
- Los Angeles General Medical Center
-
수석 연구원:
- Joshua L Gary, MD
-
연락하다:
- Joshua Gary, MD
- 전화번호: +13234426984
- 이메일: OrthoTraumaResearch@med.usc.edu
-
San Francisco, California, 미국, 94143
- 모병
- University of California San Francisco
-
수석 연구원:
- Saam Morshed, MD
-
연락하다:
- Saam Morshed, MD
- 이메일: Saam.morshed@ucsf.edu
-
-
Florida
-
Miami, Florida, 미국, 33146
- 아직 모집하지 않음
- University of Miami
-
연락하다:
- Giselle Hernandez, MD
- 이메일: g.hernandez@med.miami.edu
-
수석 연구원:
- Giselle Hernandez, MD
-
-
Indiana
-
Bloomington, Indiana, 미국, 47405
- 모병
- Indiana University
-
수석 연구원:
- Dillon O'Neill, MD
-
연락하다:
- Dillon O'Neill, MD
- 이메일: doneill5@iuhealth.org
-
-
Maryland
-
Baltimore, Maryland, 미국, 21201
- 모병
- University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center
-
수석 연구원:
- Mark Gage, MD
-
연락하다:
- Mark Gage, MD
- 이메일: mgage@som.umaryland.edu
-
Largo, Maryland, 미국, 20774
- 모병
- University of Maryland Capital Region Health
-
수석 연구원:
- Todd Jaeblon, MD
-
연락하다:
- Todd Jaeblon, MD
- 이메일: tjaeblon@som.umaryland.edu
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02215
- 아직 모집하지 않음
- Beth Israel Deaconess Medical Center
-
연락하다:
- Ishaq Ibrahim, MD
- 이메일: ioibrahi@bidmc.harvard.edu
-
수석 연구원:
- Ishaq Ibrahim, MD
-
Boston, Massachusetts, 미국, 02115
- 모병
- Massachusetts General Brigham
-
연락하다:
- Michael Weaver, MD
- 이메일: MJWEAVER@BWH.HARVARD.EDU
-
수석 연구원:
- Michael Weaver, MD
-
-
Mississippi
-
University, Mississippi, 미국, 38677
- 모병
- University of Mississippi
-
수석 연구원:
- Patrick Bergin, MD
-
연락하다:
- Patrick Bergin, MD
- 이메일: pbergin@umc.edu
-
-
New York
-
New York, New York, 미국, 10016
- 모병
- NYU Langone Health
-
수석 연구원:
- Ran Schwarzkopf, MD
-
연락하다:
- Daniel Waren
- 이메일: Daniel.waren@nyulangone.org
-
-
Ohio
-
Cincinnati, Ohio, 미국, 45221
- 모병
- University of Cincinnati
-
연락하다:
- Michael Beltran, MD
- 이메일: beltrame@ucmail.uc.edu
-
수석 연구원:
- Michael Beltran, MD
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73104
- 모병
- University of Oklahoma Health Sciences Center
-
수석 연구원:
- Brandon Hull, MD
-
연락하다:
- Brandon Hull, MD
- 이메일: Brandon-Hull@ou.edu
-
-
Pennsylvania
-
Allentown, Pennsylvania, 미국, 18102
- 모병
- St. Luke's University Health System
-
수석 연구원:
- Dustin Greenhill, MD
-
연락하다:
- Dustin Greenhill, MD
- 이메일: dustin.greenhill@sluhn.org
-
-
South Carolina
-
Greenville, South Carolina, 미국, 29601
- 모병
- Prisma Health-Upstate
-
수석 연구원:
- Kyle Jeray, MD
-
연락하다:
- Kyle Jeray, MD
- 이메일: kyle.jeray@prismahealth.org
-
-
Tennessee
-
Nashville, Tennessee, 미국, 37235
- 모병
- Vanderbilt University
-
연락하다:
- Lauren Tatman, MD
- 이메일: lauren.m.tatman@vumc.org
-
수석 연구원:
- Lauren Tatman, MD
-
-
Utah
-
Salt Lake City, Utah, 미국, 84108
- 모병
- University of Utah
-
수석 연구원:
- Lucas Marchand, MD
-
연락하다:
- Lucas Marchand, MD
- 이메일: lucas.marchand@hsc.utah.edu
-
-
Vermont
-
Burlington, Vermont, 미국, 05405
- 아직 모집하지 않음
- University of Vermont
-
연락하다:
- Michael Blankstein, MD
- 이메일: michael.blankstein@uvmhealth.org
-
수석 연구원:
- Michael Blankstein, MD
-
-
Virginia
-
Fairfax, Virginia, 미국, 22031
- 모병
- Inova Health Care Services
-
수석 연구원:
- Greg Gaski, MD
-
연락하다:
- Grag Gaski, MD
- 이메일: greg.gaski@inova.org
-
-
Wisconsin
-
Madison, Wisconsin, 미국, 53706
- 모병
- University of Wisconsin - Madison
-
수석 연구원:
- Chris Domes, MD
-
연락하다:
- Chris Domes, MD
- 이메일: domes@ortho.wisc.edu
-
-
-
-
-
Barcelona, 스페인
- 아직 모집하지 않음
- Hospital Universitari Vall d'Hebron
-
연락하다:
- Carlos Alberto Piedra-Calle, MD
- 이메일: carlosalberto.piedra@vallhebron.cat
-
수석 연구원:
- Carlos Alberto Piedra-Calle, MD
-
Barcelona, 스페인
- 아직 모집하지 않음
- Consorci Sanitari de l'Alt Penedès i Garraf (CSAPG)
-
수석 연구원:
- Alfred Dealbert, MD
-
연락하다:
- Alfred Dealbert Dealbert, MD
- 이메일: adealbert@csapg.cat
-
Barcelona, 스페인, 08221
- 아직 모집하지 않음
- Hospital Universitario Mutua de Terrassa
-
연락하다:
- Pablo Castillon Bernal, MD
- 이메일: pablocastillon@mutuaterrassa.es
-
수석 연구원:
- Pablo Castillon Bernal, MD
-
Barcelona, 스페인
- 아직 모집하지 않음
- FRCB-IDIBAPS (Hospital Clinic Barcelona)
-
연락하다:
- Pilar Camacho, MD
- 이메일: PCAMACHO@clinic.cat
-
수석 연구원:
- Pilar Camacho, MD
-
-
-
-
-
Edinburgh, 영국, EH8 8BG
- 아직 모집하지 않음
- University of Edinburgh
-
연락하다:
- Andrew Duckworth, MD
- 이메일: andrew.duckworth@ed.ac.uk
-
-
-
-
-
Ottawa, 캐나다, K1H 8L6
- 아직 모집하지 않음
- The Ottawa Hospital
-
연락하다:
- Bradley Meulenkamp, MD
- 이메일: bmeulenkamp@toh.ca
-
수석 연구원:
- Bradley Meulenkamp, MD
-
-
British Columbia
-
Vancouver, British Columbia, 캐나다, V6T 1Z4
- 모병
- University of British Columbia
-
연락하다:
- Aresh Sepehri, MD
-
연락하다:
- 이메일: aresh.sepehri@vch.ca
-
수석 연구원:
- Aresh Sephri, MD
-
Vancouver, British Columbia, 캐나다
- 모병
- Fraser Health Authority
-
연락하다:
- Darius Viskontas, MD
- 전화번호: 604-777-5577
- 이메일: dariusviskontas@yahoo.ca
-
연락하다:
- 전화번호: 604-777-5577
-
수석 연구원:
- Darius Viskontas, MD
-
-
Ontario
-
London, Ontario, 캐나다, N6A 5W9,
- 모병
- London Health Sciences Centre
-
연락하다:
- Emil Schemitsch, MD
- 이메일: emil.schemitsch@lhsc.on.ca
-
수석 연구원:
- Emil Schemitsch, MD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- 60 years of age or older undergoing surgery due to a minimally displaced femoral neck fracture
- The patient has a health condition affecting physical mobility.
- Complete fracture of the femoral neck (AO/OTA 31B) confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging.
- Minimally displaced fracture that could be, in the judgment of the attending surgeon, managed with either arthroplasty or in situ internal fixation without reduction.
- Low energy injury mechanism.
- Surgeons with expertise in internal fixation and total hip arthroplasty or hemiarthroplasty are available to perform surgery.
Exclusion Criteria:
- The patient is not clinically suitable for either compared treatment.
- Expected injury survival of less than 12 months.
- Terminal illness with expected survival of less than 12 months.
- Incarceration.
- Unable to obtain informed consent due to language barriers.
- Unable to obtain informed consent because the legally authorized representative was unavailable.
- Problems, in the judgment of the study personnel, with maintaining follow-up with the patient.
- Currently enrolled in a study or intervention domain that does not permit co-enrollment.
- Prior enrollment in the specific platform trial intervention domain.
- Patient or legally authorized representative did not provide informed consent (declined participation).
- Eligible patient or legally authorized representative was not approached within the screening window (missed participant).
- Other reasons to exclude the patient, as approved by the data coordinating center.
- Associated lower extremity injury that prevents post-operative weight-bearing.
- Retained hardware around the hip that precludes either study treatment.
- Infection around the hip (soft tissue or bone).
- Pathologic fracture with a lytic lesion in the femoral neck that precludes internal fixation.
- Injury did not occur within 21 days of screening.
- Patient is too ill, in the judgment of the attending surgeon, for internal fixation.
- Patient is too ill, in the judgment of the attending surgeon, for arthroplasty.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: 고관절 치환술
|
Participants will undergo surgical treatment using standard hip arthroplasty techniques for femoral minimally displaced femoral neck fracture. A modern porous-coated press-fit or cemented hip arthroplasty prosthesis will be used at the treating surgeon's discretion. Press-fit implants that have no ingrowth or ongrowth surface will not be permitted. The type of hip prosthesis (hemiarthroplasty or total hip arthroplasty), bearing (single or dual mobility), or the method of arthroplasty fixation (cemented or uncemented) will be at the discretion of the treating surgeon. |
|
활성 비교기: 내고정
|
Participants will undergo surgical treatment using standard fixation techniques for minimally displaced femoral neck fractures. The treating surgeon may perform fracture reduction maneuvers if desired. Fixed-angle devices and multiple screws will be permitted. The internal fixation device(s) will be inserted through a small lateral incision. Internal fixation constructs combining cancellous screws and fixed-angle devices will be permitted. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Composite outcome of death, ambulation status, and days alive and out of hospital.
기간: 120 days after randomization
|
Death consists of time to all-cause mortality. Ambulation will be evaluated using an ordinal ranking of independence. Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
120 days after randomization
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Composite outcome of death, ambulation status, and days alive and out of hospital.
기간: 365 days after randomization
|
Death consists of time to all-cause mortality. Ambulation will be evaluated using an ordinal ranking of independence. Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
365 days after randomization
|
|
Death
기간: 120 days post-randomization
|
Death consists of time to all-cause mortality. |
120 days post-randomization
|
|
Death
기간: 12 months post-randomization
|
Death consists of time to all-cause mortality. |
12 months post-randomization
|
|
Ambulation status
기간: 120 days post-randomization
|
Ambulation will be evaluated using an ordinal ranking of independence |
120 days post-randomization
|
|
Ambulation status
기간: 12 months post-randomization
|
Ambulation will be evaluated using an ordinal ranking of independence |
12 months post-randomization
|
|
Days alive and out of hospital
기간: 120 days post-randomization
|
Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
120 days post-randomization
|
|
Days alive and out of hospital
기간: 12 months post-randomization
|
Days alive and out of hospital will be calculated by subtracting the sum of days meeting one of two criteria below:
|
12 months post-randomization
|
|
Health-related quality of life
기간: 120 days days post-randomization
|
EQ-5D-5L - Range: 0 to 1, Higher scores indicates better self-perceived health |
120 days days post-randomization
|
|
Health-related quality of life
기간: 12 months post-randomization
|
EQ-5D-5L - Range: 0 to 1, Higher scores indicates better self-perceived health |
12 months post-randomization
|
|
Numeric Pain Rating Scale
기간: During hospitalization in the first seven postoperative days
|
The highest level of pain recorded daily in the participant's medical record - Range: 0-10, higher score indicates higher level of pain |
During hospitalization in the first seven postoperative days
|
공동 작업자 및 조사자
협력자
수사관
- 수석 연구원: Joseph T Patterson, MD, University of Southern California
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- BPS-2024C1-37436
- BPS-2024C1-37436 (기타 보조금/기금 번호: Patient-Centered Outcomes Research Institute)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .